Bap Pharma Ltd
Bap Pharma Ltd, a prominent player in the pharmaceutical industry, is headquartered in Great Britain and operates extensively across Europe and beyond. Founded in 2005, the company has established itself as a leader in the development and distribution of high-quality generic and specialty pharmaceuticals. Bap Pharma's core offerings include a diverse range of medications that cater to various therapeutic areas, including oncology, cardiology, and infectious diseases. What sets Bap Pharma apart is its commitment to innovation and quality, ensuring that all products meet stringent regulatory standards. With a strong market position, Bap Pharma has achieved significant milestones, including numerous successful product launches and partnerships that enhance its global reach. The company continues to focus on improving patient outcomes through its unique and effective pharmaceutical solutions.
DitchCarbon Score
How does Bap Pharma Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bap Pharma Ltd's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bap Pharma Ltd's reported carbon emissions
Bap Pharma Ltd, headquartered in Great Britain, currently does not have any publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company may be engaged in various climate commitments and initiatives typical within the pharmaceutical industry, focusing on sustainability and reducing environmental impact. As the industry increasingly prioritises climate action, Bap Pharma Ltd may be exploring strategies to enhance energy efficiency, reduce waste, and implement sustainable practices in their operations. For a comprehensive understanding of their climate commitments and any future emissions data, further information would be required.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bap Pharma Ltd is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
